PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Olliaro P et al. - The available treatments for VL are cost-effective, and the mortality and incidence-based methods produce consistent estimates. The combinations considered here were more cost-effective than most monotherapies. Having multiple treatment options and combining drugs are also likely to reduce drug pressure and prolong the drugs' life-span of effective use.

Related Articles

Cutaneous leishmaniasis treated with itraconazole
Dermatologic Therapy, 11/20/09    Relevance Score: 85%%

Cutaneous and mucocutaneous leishmaniasis
Dermatologic Therapy, 11/20/09    Relevance Score: 85%%

Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent
Tropical Medicine & International Health, 11/17/09    Relevance Score: 84%%

Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
Clinical and Experimental Dermatology, 11/17/09    Relevance Score: 84%%

The Antituberculosis Drug Pyrazinamide Affects the Course of Cutaneous Leishmaniasis In Vivo and Increases Activation of Macrophages and Dendritic Cells
Antimicrobial Agents and Chemotherapy, 11/20/09    Relevance Score: 83%%

Today in Infectious Disease...keeping you current

CDC Estimates 22 Million Americans Have Been Ill With H1N1 Influenza. People With Diabetes, Asthma Account for High Percentage of Hospitalizations
American Family Physician, 12/04/09

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
New England Journal of Medicine, 12/04/09

Bacteriophage Therapy of Salmonella enterica: A Fresh Appraisal of Bacteriophage Therapy
The Journal of Infectious Diseases, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address